Zurich Cantonal Bank
MRTX

Zurich Cantonal Bank’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Zurich Cantonal Bank’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,666
Closed -$627K – 2757
2023
Q4 		$627K Sell
10,666
-687
-6% -$38.6K ﹤0.01% 1364
2023
Q3 		$495K Buy
11,353
+4,472
+65% +$160K ﹤0.01% 1414
2023
Q2 		$249K Buy
6,881
+981
+17% +$40.4K ﹤0.01% 1783
2023
Q1 		$219K Hold
5,900
– – ﹤0.01% 1807
2022
Q4 		$267K Buy
5,900
+1,026
+21% +$66.4K ﹤0.01% 1644
2022
Q3 		$340K Hold
4,874
– – ﹤0.01% 1429
2022
Q2 		$327K Hold
4,874
– – ﹤0.01% 1498
2022
Q1 		$401K Sell
4,874
-230
-5% -$23.5K ﹤0.01% 1469
2021
Q4 		$749K Buy
5,104
+1,199
+31% +$186K ﹤0.01% 1174
2021
Q3 		$691K Buy
3,905
+9
+0.2% +$1.45K ﹤0.01% 1095
2021
Q2 		$629K Sell
3,896
-210
-5% -$33.7K ﹤0.01% 1095
2021
Q1 		$703K Buy
4,106
+572
+16% +$113K ﹤0.01% 1019
2020
Q4 		$776K Buy
3,534
+247
+8% +$53.4K ﹤0.01% 1061
2020
Q3 		$546K Hold
3,287
– – ﹤0.01% 1050
2020
Q2 		$375K Buy
3,287
+1,172
+55% +$114K ﹤0.01% 1155
2020
Q1 		$163K Buy
2,115
+182
+9% +$16.3K ﹤0.01% 1321
2019
Q4 		$249K Buy
1,933
+511
+36% +$49.3K ﹤0.01% 1220
2019
Q3 		$111K Hold
1,422
– – ﹤0.01% 1564
2019
Q2 		$146K Buy
1,422
+235
+20% +$18.3K ﹤0.01% 1402
2019
Q1 		$87K Sell
1,187
-487
-29% -$33.1K ﹤0.01% 1661
2018
Q4 		$71K Hold
1,674
– – ﹤0.01% 1816
2018
Q3 		$79K Hold
1,674
– – ﹤0.01% 1866
2018
Q2 		$83K Buy
+1,674
New +$63.2K ﹤0.01% 1763
2016
Q4 		– Sell
-365
Closed -$2K – 2579
2016
Q3 		$2K Hold
365
– – ﹤0.01% 2551
2016
Q2 		$2K Hold
365
– – ﹤0.01% 2543
2016
Q1 		$8K Hold
365
– – ﹤0.01% 2434
2015
Q4 		$12K Buy
+365
New +$12.9K ﹤0.01% 2316

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Zurich Cantonal Bank's MRTX Position: Q1 2024 in Review

Zurich Cantonal Bank sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 10,666 shares — an estimated $627K sold.

Zurich Cantonal Bank first reported a position in MRTX in Q4 2015 and held it in 27 quarters. The position peaked at $776K in Q4 2020. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Zurich Cantonal Bank reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Zurich Cantonal Bank sold 10,666 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $627K.
  • Zurich Cantonal Bank first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2015 and held it in 27 quarters.
  • Zurich Cantonal Bank's Mirati Therapeutics, Inc. Common Stock position peaked at $776K in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Zurich Cantonal Bank's 13F filing for Q1 2024, filed 25 Apr 2024.